PHARMACOLOGICAL CHALLENGES AND OUTCOMES IN DIABETIC PATIENTS UNDERGOING DENTAL PROCEDURES: A CLINICAL STUDY IN A TERTIARY CARE CENTRE OF JHARKHAND
Main Article Content
Keywords
Diabetes mellitus, Dental procedures, Pharmacological challenges, Glycemic control, Wound healing, Postoperative infection etc.
Abstract
Background: Diabetes mellitus is a chronic metabolic disorder associated with impaired immune response, altered pharmacokinetics, and delayed wound healing, all of which complicate dental management and pharmacological decision-making. Diabetic patients undergoing dental procedures are at increased risk of postoperative infection, delayed tissue repair, and adverse drug interactions, particularly in the presence of poor glycemic control. This study aimed to evaluate the pharmacological challenges encountered during routine dental procedures in diabetic patients and to assess clinical outcomes, including pain control, wound healing, infection rates, and drug-related complications, in relation to glycemic status.
Materials and Methods: This hospital-based clinical study was conducted over six months (January 2025 to June 2025) in the Department of Dentistry at Laxmi Chandravansi Medical College and Hospital. A total of 120 adult patients with type 1 or type 2 diabetes mellitus undergoing routine dental procedures were included. Data regarding demographic characteristics, glycemic status, dental procedures performed, pharmacological agents used, and clinical outcomes were recorded. Associations between pharmacological factors, glycemic control, and clinical outcomes were analyzed using the Chi-square test or Fisher’s exact test, with a p-value <0.05 considered statistically significant.
Results: Dental extractions were the most common procedures performed (37.5%). Local anesthesia with vasoconstrictors was used in 70.8% of patients, while analgesics and antibiotics were prescribed to 91.7% and 50% of patients, respectively. Adequate intraoperative pain control was achieved in 93.3% of cases. Delayed wound healing (p = 0.01) and postoperative infections (p = 0.04) were significantly more common in patients with poor glycemic control. Drug–drug interactions and hypoglycemic episodes were infrequent and managed conservatively without major complications.
Conclusion: Diabetic patients can safely undergo routine dental procedures with satisfactory outcomes when pharmacological management is individualized. Poor glycemic control remains a significant risk factor for delayed healing and postoperative infections, highlighting the importance of metabolic optimization and interdisciplinary care in dental practice.
References
2. Preshaw PM, Alba AL, Herrera D, Jepsen S, Konstantinidis A, Makrilakis K, Taylor R. Periodontitis and diabetes: a two-way relationship. Diabetologia. 2012;55(1):21–31.
3. Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol. 2001;6(1):99–112.
4. Lalla E, Papapanou PN. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat Rev Endocrinol. 2011;7(12):738–48.
5. Malhotra N, Sohi RK, Bala K. Local anesthetic considerations in diabetic patients. J Dent Anesth Pain Med. 2016;16(1):1–8.
6. Lalla RV, Papapanou PN. Systemic conditions affecting oral health: pharmacological considerations. Periodontol 2000. 2016;71(1):120–36.
7. Preshaw PM, Bissett SM. Periodontitis and diabetes. Br Dent J. 2019;227(7):577–84.
8. Genco RJ, Borgnakke WS. Risk factors for periodontal disease. Periodontol 2000. 2013;62(1):59–94.
9. Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008;117(24):3118–25.
10. de Molon RS, Rodrigues JVS, Deroide MB, Garcia VG, Theodoro LH. Antibiotics as adjuncts to periodontal therapy in diabetic patients: a systematic review. J Clin Med. 2024;13:1240.
11. Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function in diabetes mellitus. Diabetes Care. 1992;15(2):256–60.
12. Guo S, DiPietro LA. Factors affecting wound healing. J Dent Res. 2010;89(3):219–29.
13. Rao A, Thomas B, Prasad S. Healing after dental extraction in patients with diabetes mellitus. J Indian Soc Periodontol. 2021;25(4):312–6.
14. Al-Maskari AY, Al-Mutawa SA, Al-Sabah KA. Oral manifestations and complications of diabetes mellitus. Saudi J Oral Sci. 2021;8(1):45–52.
15. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med. 1997;14(1):29–34.
16. Saini R, Saini S, Sharma S. Antibiotic prophylaxis in diabetic patients undergoing dental procedures. Oral Health Prev Dent. 2022;20(1):341–9.
17. Lodi G, Figini L, Sardella A, Carrassi A, Del Fabbro M, Furness S. Antibiotics to prevent complications following tooth extractions. Cochrane Database Syst Rev. 2012;(11):CD003811.
18. Brunton LL, Hilal-Dandan R, Knollmann BC. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 14th ed. New York: McGraw-Hill; 2023.
19. Little JW, Falace DA, Miller CS, Rhodus NL. Dental Management of the Medically Compromised Patient. 9th ed. St Louis: Elsevier; 2018.
20. Vinik AI, Casellini C. Diabetic neuropathy. Endocrinol Metab Clin North Am. 2013;42(4):747–87.
21. Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521–34.
22. Preshaw PM, Alba AL, Herrera D, et al. Periodontitis and diabetes: a two-way relationship. Diabetologia. 2012;55(1):21–31.
23. Genco RJ, Borgnakke WS. Diabetes as a risk factor for periodontal disease. Periodontol 2000. 2020;83(1):59–74.

